Experimental Ebola Vaccines Provide Year-Long Antibody Responses In Liberia Trial

CIDRAP News: Liberia trial finds Ebola vaccines yield year-long immune response “A trial at the end of Liberia’s Ebola outbreak of two candidate vaccines that were furthest along in development at the time showed both posed no major safety concerns and triggered immune responses that lasted at least a year, researchers from a U.S.-Liberian clinical…More

Read more from the original source:
Experimental Ebola Vaccines Provide Year-Long Antibody Responses In Liberia Trial